A month of back-and-forth has resulted in a Takeda (NASDAQOTH: TKPHF)and Shire Plc (NASDAQ: SHPG)striking a deal to form the eight biggest drugmaker in the world. The merger's $62 billion cost, however, could be a problem, especially if it dings Takeda's credit rating.
Takeda and Shire: A Pricey Marriage
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться